• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Yangguang,WU Meng,CEN Shan,ZHOU Jinming.Design strategy of anti-androgen targeting the non-HBP sites of androgen receptor[J].Journal Of Pharmaceutical Research,2017,36(5):249-254,258[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3441times   Download 3871次 QR Code for this article
Scan with your phone!
非雄激素竞争型雄激素受体拮抗剂设计策略
刘阳光,吴萌,岑山,周金明
Font:Larger+|Default|Smaller-
(中国医学科学院、北京协和医学院医药生物技术研究所,北京 100050)
摘要:
雄激素受体(androgen receptor ,AR)是前列腺癌治疗中最为重要的药物靶点,但抗雄激素药物在使用过程中产生的耐药性问题给前列腺癌患者的治疗带来了巨大挑战。本文回顾了AR的结构功能及传统治疗位点产生药物抗性的原因,并总结非雄激素竞争型的AR拮抗剂设计策略,为发展新型抗前列腺癌药物提供依据。
关键词:  雄激素受体  抗前列腺癌  雄激素受体拮抗剂  激活功能区2  结合功能区3  去势抵抗性前列腺癌
DOI:10.13506/j.cnki.jpr.2017.05.001
基金项目:国家自然科学基金(No.81672559、No.81001402、No.81311120299)
Design strategy of anti-androgen targeting the non-HBP sites of androgen receptor
LIU Yangguang,WU Meng,CEN Shan,ZHOU Jinming
(Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China)
Abstract:
Androgen receptor (AR) is the most important target for the therapy of prostate cancer.However,the drug resistance during the treatment becomes the greatest challenge.Herein,we gave an overview of the structure and functions of AR and the drug resistances due to the mutations in the HBP site.Then this article summarized the design strategy of the AR antagonists targeting the non-HBP sites of AR,which should help to the development of novel anti-prostate cancer drugs.
Key words:  Androgen receptor  Anti-prostate cancer  Anti-androgen  AF2  BF3  CRPC
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.